Skip to main content
OpenTrials

Clinical trial condition

Rhabdomyosarcoma

Explore clinical trials studying Rhabdomyosarcoma. Study availability and eligibility vary by location and protocol.

186 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Rhabdomyosarcoma trial results

Recruiting

VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors

NCT04796012

Conditions
Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +5 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

NCT04901702

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +55 more
Locations
  • Lucille Packard Children's Hospital Stanford Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta/Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Recruiting

Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)

NCT06094101

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • Pediatrics III, West German Cancer Centre, University Hospital Essen, Germany
  • Universitätsklinikum, Klinik für Kinder- und Jugendmedizin Frankfurt am Main, Germany
  • Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg im Breisgau, Germany
  • University Children's Hostpital Tübingen, Germany
View Trial Details
Recruiting

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

NCT06441331

Conditions
CNS Tumors, Central Nervous System Neoplasms, GIST, +29 more
Locations
  • The Children's Hospital of Philadelphia (CHOP) Philadelphia, Pennsylvania, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • Gustave Roussy Cancer Campus Villejuif, France
  • Hospital Universitario Vall d'Hebron - Oncología Médica Barcelona, Spain
View Trial Details

Related conditions